Tag: January 2019

Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential

 J Clin Aesthet Dermatol. 2019;12(1):11–15 by James Q. Del Rosso, DO; Leon Kircik, MD; Tina Lin PharmD; and Radhakrishnan Pillai, PhD Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology in Las Vegas, Nevada. Dr. Kircik is with the Indiana University School of Medicine in Indianapolis, Indiana; Physicians Skin Care, PLLC in Louisville, Kentucky; and


Fractionated Carbon Dioxide Laser Resurfacing as an Ideal Treatment Option for Severe Rhinophyma: A Case Report and Discussion

 J Clin Aesthet Dermatol. 2019;12(1):24–27 by Victoria Comeau DO, PGY II; Marcus Goodman, DO; Mary Margaret Kober, MD; and Christopher Buckley, DO Drs. Comeau, Goodman, and Buckley are with the Department of Dermatology at Philadelphia College of Osteopathic Medicine in Roswell, Georgia. Drs. Goodman, Kober, and Buckley are also with Goodman Dermatology in Roswell, Georgia. 


Advanced Presentation of Homeopathically Treated Giant Melanoma: A Case Report

 J Clin Aesthet Dermatol. 2019;12(1):28–31 by Andrew Duncanson, DO; Michael Kopstein, DO; and Stanley Skopit, DO, MSE, FAOCD, FAAD Drs. Duncanson and Skopit are with the Larkin Community Hospital/LECOM Dermatology Residency Training Program in Miami, Florida. Dr. Kopstein is with the Sky Ridge Medical Center/RVUCOM Internal Medicine Residency Training Program in Lone Tree, Colorado. Funding: No


Effective Treatment of Morbihan’s Disease with Long-term Isotretinoin: A Report of Three Cases

 J Clin Aesthet Dermatol. 2019;12(1):32–34 by Verónica Olvera-Cortés, MD, and Nancy Pulido-Díaz, MD Drs. Olvera-Cortés and Pulido-Díaz are with the Dermatology Department at the Mexican Institute of Social Security and National Medical Center La Raza in Mexico City, Mexico. Funding: No funding was received for this study. Disclosures: The authors have no conflicts of interest